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Abstract  
 
Decoctions and infusions of Artocarpus communis (Forst.) (family: Moraceae) root-bark are commonly 
used traditionally among the Yoruba-speaking people of Western Nigeria as  folk remedies for the management, 
control and/or treatment of an array of human diseases, including type 2, adult-onset diabetes mellitus. Although 
numerous bioactive flavonoids have been isolated from the roots, stem-bark and leaves of A. communis, to the best 
of our knowledge, the effects of the plant’s root-bark extract on animal model of diabetes mellitus and on liver 
tissues have hitherto, not been reported in the biomedical literature. In view of this, the present study was undertaken 
to investigate the glycaemic effect of, and hepatic tissue ultrastructural, morphological and metabolic changes 
induced by, A. communis root-bark aqueous extract (ACE) in Wistar rats. The ultrastructural, morphological and 
metabolic effects of ACE have been compared with those induced by streptozotocin (STZ) in rat experimental 
paradigms. Four groups (A, B, C and D) of Wistar rats, each group containing 10 rats, were used. Diabetes mellitus 
was induced in the diabetic groups B and C animals by intraperitoneal injections of STZ (75 mg/kg body weight), 
while group A rats received A. communis root-bark aqueous extract (ACE, 100 mg/kg body weight, i.p.) alone. 
Control group D rats received distilled water in quantities equivalent to the volume of ACE administered 
intraperitoneally. The rats in group C were additionally treated with ACE (100 mg/kg body weight i. p.) daily from 
day 3 to day 10 after STZ treatment. Hepatic glucokinase, hexokinase, glutamate dehydrogenase, succinate 
dehydrogenase, β-hydroxybutyrate dehydrogenase, serum insulin and blood glucose levels of the animals were 
measured and recorded before and after ACE, STZ and STZ+ACE treatments. Hepatic tissues were also processed 
for transmission electron microscopy. Electron microscopic examinations showed toxic, deleterious alterations in 
the ultrastructures of groups A, B and C hepatic cells, the most prominent deleterious effects being on the 
hepatocytes. Ultrastructural changes observed within the hepatocytes of groups A, B and C rats include disrupted 
mitochondria with increase in lipid droplets, extensive hepatocellular vacuolation, scanty rough endoplasmic 
reticulum (RER) and ribosomes. Large glycogen clusters were also noticed displacing the mitochondria and RER in 
group A rats. Group A rats also developed significant hyperglycemia (p<0.05) immediately after ACE 
administration, while groups B and C rats developed hyperglycemia 24 hours after STZ treatment. When compared 
with the control group D rats, the activities of all the three subsystems were disrupted, leading to overall inhibition 
of oxidative phosphorylation of the liver mitochondria in groups A, B and C rats, but remain normal in the untreated 
group D control rats. The findings of the present study indicate that A. communis root-bark aqueous extract induces 
hyperglycaemia in the experimental animal model used, and that the plant’s extract disrupts the ultrastructural 
characteristics and architecture of hepatocytes as well as oxidative energy metabolism.  
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Introduction 
      
                Artocarpus communis (Forst.) is a perennial, evergreen, terrestrial, single-stemmed, erect flowering plant,  
popularly known in English as “breadfruit” tree because of the “bread-like texture” of its edible fruits. It is a 
member of the Moraceae family which consists of about 50 genera and over 1000 species (Tindal, 1965). The 
‘breadfruit’ tree is a fast growing plant of up to 20–30 metres in height, with a trunk of up to 1–2 metres in diameter. 
All the morphological parts of the tree, including the unripe fruit, are rich in milky, gummy latex. The shoots, bark 
and latex of the plant have been reported to have many traditional, ethnomedical uses. For example, in the West 
Indies, a decoction of the plant’s leaves is used to lower elevated blood pressure and to relieve asthma. In Taiwan, 
the leaves are used for fever and liver disorders, while the sap is used for thrush, stomach pain, and dysentery. Root 
extracts of the plant are used as antibacterial remedy against gram-positive bacteria, and as anticancer agents 
(Kasahara and Hemmi, 1986). In Nigeria, the root-bark of A. communis is traditionally used for a variety of human 
ailments, including management or treatment of diarrhea, dysentery as well as for diabetes mellitus. Natural 
compounds isolated from A. communis roots, stem and leaves include prenylflavonoids, dihydrocycloartomunin, 
dihydroisocyloartomunin, heteroflavanones, cylomorusin, artonins A and B, cycloheterhyllin, cyclocomunin, 
cycloartomunin   artocarpanone A, and cudraflavone (Chan et al., 2003; Lin et al., 1991), and flavonoids, 
dihydroartomunoxanthone, artomunoisoxanthone, cyclocomunomethonol and artomunoflavanone (Wang et al., 
2004). Some of these compounds possess significant anti-platelet (Lin et al., 1993) and anti-inflammatory (Wei et 
al., 2005) activities. Generally, flavonoids constitute a group of naturally-occurring chemical compounds widely 
distributed as secondary metabolites in the plant kingdom. They have been recognized for having interesting 
pharmacological properties, such as anti-inflammatory, antiallergic, antiviral, antibacterial, and antitumoral activities 
(Middleton, 1998). One of these flavonoids, quercetin (3,5,7,3´,4´-pentahydroxyflavone), prevents oxidantive injury 
and cell death by several mechanisms, including scavenging oxygen radicals (Inal et al., 2002), protecting cells and 
tissues against lipid peroxidation, and chelating metal ions (Afanas’ve et al., 1989). 
It is known that streptozotocin (STZ)-induced diabetes mellitus causes functional and structural changes in 
some tissues and organs of animals. However, the mechanism of the cytotoxic action of STZ is not fully understood. 
Experimental evidence has also demonstrated that some of the toxic, deleterious effects of STZ are attributable to 
induction of metabolic processes, which lead on to an increase in the generation of reactive oxygen species (ROS) 
(Chen et al; 1990). Apart from production of ROS, STZ also inhibits free radical scavenger-enzymes (Kröncke et al; 
1995). The superoxide radical has been implicated in lipid peroxidation, DNA damage, and sulphydryl oxidation 
(Tiedge et al; 1997; Matkovics et al; 1998).  
The basic defects in diabetes mellitus include impaired glucose metabolism and basement membrane 
alterations (Striker et al., 1993). Besides, mitochondrial oxidative energy metabolism also seems to be impaired in 
experimental diabetes (Brady et al., 1985). With regard to mitochondrial respiratory activity, the regulatory factors 
which are affected in diabetes are glutamate, succinate and β-hydroxybutyrate dehydrogenase (Park and Drake, 
1982).  Thus, mitochondria seem to be the direct targets of the diabetic state (Berdanier, 2001). There are several 
reasons why crude medicinal plant products used as herbal medicines should be studied. Although herbal remedies 
may have recognizable therapeutic effects (Bailey and Day, 1989), they may also have toxic side-effects (Keen et al; 
1994). Not only is there an absence of documented toxicity profile for most herbs, but also there is no standard 
system for reporting adverse reactions to herbal medicines. To the lay public, ‘natural’ is equivalent and related to 
‘safety’. This is, however, a false assumption.  
The present study was prompted by the claim of some traditional health practitioners in Western Nigeria 
that decoctions and infusions of A. communis root-bark are effective remedies for the management and/or control of 
type 2, adult-onset diabetes mellitus. The core aims of the present study were, therefore, to examine the (i) 
glycaemic effect of A. communis root-bark aqueous extract in rats, (ii) effects of the plant’s root-bark extract on the 
morphology of hepatocytes, and (iii) effects of the plant’s root-bark extract on the oxidative energy metabolism of 
liver mitochondria in ACE-, STZ-, STZ-+ACE-treated rats and various liver tissues of rats.        
 
 
Materials Methods 
 
The experimental protocol and procedures used in this study were approved by the Ethics Committee of the 
University of Durban-Westville, Durban 4000, South Africa; and conform with the “Guide to the Care and Use of 
Animals in Research and Teaching” [Published by the Ethics Committee of the University of Durban-Westville, 
Durban 4000, South Africa]. 
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Animals 
 
 This study was carried out in healthy, male and female Wistar rats, weighing 250-300 g. The animals were  
housed under standard laboratory conditions of light, temperature and humidity. The animals were given standard rat 
pellets and tap water ad libitum. The rats were randomly divided into four experimental groups: Group A (A. 
communis root-bark extract-treated), Group B (STZ-treated), Group C (STZ-+ A. communis root-bark extract-
treated), and Group D (distilled water-treated control) rats. Each group consisted of 10 rats. All the animals were 
fasted for 16 hours, but still allowed free access to water, before the commencement of our experiments. 
 
Plant material 
 
            The root-bark of Artocarpus communis (Forst.) [family: Moraceae] (locally known by its common English 
name of “Breadfruit” or “Gbere” in Yoruba language of Western Nigeria) were collected in Ile-Ife, Western Nigeria, 
between April and May 2006. Pieces of the plant’s root-bark were identified by the Taxonomist/Curator of the 
Department of Botany, Obafemi Awolowo University, Ile-Ife, Nigeria, as those of A. communis Forst. (family, 
Moraceae). A voucher specimen of the plant has been deposited in the Herbarium of the University’s Botany 
Department.  
 
Preparation of Artocarpus communis root-bark aqueous extract 
 
             Pieces of Artocarpus communis fresh root-bark were air-dried at room temperature. One kilogram (1 kg) of 
the air-dried root bark of the plant was milled into fine powder in a Waring commercial blender. The powdered root-
bark was macerated in distilled water and extracted twice, on each occasion with 2.5 1itres of distilled water at room 
temperature for 48 h. The combined aqueous extract solubles were concentrated to dryness under reduced pressure 
at 60oC±1oC in a rotary evaporator. The resulting aqueous extract was freeze-dried, finally giving 56.23 g (i.e., 
5.62% yields) of a clay-colour, powdery, crude aqueous root-bark extract of A. communis (ACE). Aliquot portions 
of the crude extract residue were weighed and dissolved in distilled water for use on each day of our experiment 
without any further purification. 
 
Acute toxicity testing 
 
            The median lethal dose (LD50) of A. communis root-bark aqueous extract (ACE) was determined in male and 
female rats (weighing 250–300 g), using a modified method of Lorke (1983). Rats fasted for 16 h were randomly 
divided into groups of 10 mice each. Graded doses of ACE (12.5, 25, 50, 100, 200, 400, 800 and 1600 mg/kg) were 
separately administered intraperitoneally to the rats in each of the ‘test’ groups. Each of the rats in the ‘control’ 
group was treated with distilled water (3 ml/kg, i.p.) only. The rats in both the ‘test’ and ‘control’ groups were then 
allowed free access to food and water, and observed over a period of 48 h for signs of acute toxicity. The number of 
deaths (produced by the extract) within this period of time was noted and recorded. Log dose-response plots were 
constructed for the plant’s extract, from which the LD50 value of the root-bark aqueous extract was determined. 
 
 
Induction of experimental diabetes mellitus  
 
               Diabetes mellitus was induced (in groups B and C ‘test’ rats) by intraperitoneal injections of STZ (75 
mg/kg i. p.), freshly dissolved in 0.1mol/l citrate buffer (Rossini et al; 1978). Group D ‘control’ rats were injected 
with volumes of distilled water equivalent to the volume of administered ACE intraperitoneally. The ‘test’ animals 
in groups B and C became diabetic within 48 hours after STZ administration. Diabetes was allowed to develop and 
stabilize in these STZ-treated rats over a period of 3–5 days. Group C rats additionally received intraperitoneal 
injections of ACE (100 mg/kg/day i.p.) daily from the 3rd to the 10th day after STZ treatment. All the animals in 
groups A, B, C and D were kept and maintained under laboratory conditions of light, humidity and temperature. 
Before the commencement of our experiments, both the control normal (normoglycemic) and STZ-treated, diabetic 
(hyperglycemic) test rats were fasted for 16-h, but still allowed free access to water throughout. At the end of the 16-
h fasting period – taken as 0 time (i.e., 0 h) – blood glucose levels (initial glycemia, G0) of the fasted normal and 
STZ-treated, diabetic rats were determined and recorded. The test compound [i.e., Artocarpus communis root-bark 
aqueous extract (ACE, 100 mg/kg i.p.)] was administered to groups A and C fasted rats.  
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Blood Glucose and serum insulin estimations  
 
 Blood samples were obtained from each rat by repeated needle puncture of the same tail tip vein.   Blood  
 samples were taken 1 day before STZ-treatment, and also on various days after induction of diabetes mellitus. 
Blood glucose concentrations were determined by means of Bayer’s Elite® Glucometer, and compatible blood 
glucose test strips (Henry, 1984). Fasted STZ–treated rats with blood glucose concentrations ≥18 mmol/L were 
considered to be diabetic, and used in this study. Serum insulin concentrations were determined by an enzyme-
linked immunosorbent assay (ELISA), using a commercial kit (Crystal Chem, Illinois, Chicago, USA).  
 
Ultrastructural examination 
 
For electron microscopy, six biopsy tissues from each group of sacrificed animals were fixed overnight in 
formaldehyde-glutaraldehyde fixative at 4oC by the method of Karnovsky (1965). The tissues were subsequently 
post-fixed in 1% osmium tetroxide. After dehydration in graded concentrations of ethyl alcohol and propylene 
oxide, the tissues were embedded in spur medium. Tissue samples were sectioned with an ultramicrotome Reichert 
Ultracut S, using a glass knife. Semi-thin sections were stained with methylene blue, and ultra-thin sections with 8% 
uranyl acetate dissolved in 50% methanol, and thereafter, in lead citrate according to the method of Venable and 
Coggeshall (1966). All studies were performed under Transmission Electron Microscope (Jeol JEM 1011) operating 
at 80 kV, and Image Analysis System (Kontron 300 and AnalySIS). The primary magnification of the Electron 
Microscopic (EM) examination was x15, 000. 
 
Hexokinase (HXK) and Glucokinase (GCK) Activities  
 
Frozen liver tissues (1 g) were homogenized at 4oC in 9 ml of cold buffer solution (pH 7.4) containing Na-
HEPES, 50 mM; KCl, 100 mM; EDTA, 1 mM; MgCl2, 5 mM and dithiothreitol (DTE), 2.5 mM, using a glass-
Teflon Potter Homogenizer. The suspension formed was centrifuged at 12000 x g for 1 h at 4oC. The clear 
supernatant formed was used for the measurement of HXK and GCK activities by coupled enzyme assay procedure 
of Davidson and Arion (1987). The incubation mixture contained the following ingredients in a final volume of 1 
ml: HEPES, 50 µmol; KCl, 100 µmol; MgCl2, 7.5 µmol; and DTE, 2.5 µmol; fatty acid free bovine serum albumin, 
10 mg; NAD+, 0.5 µmol; G-6-PD, 4 units; liver supernatant, 100 µl for HXK assay or 10 µl for total HXK and GCK 
assays; and D-glucose, 0.5 µmol for HXK and 10 µmol for total enzyme activities. Both ‘control’ and ‘test’ tubes 
were pre-incubated at 25oC for 5 min. 0.2 ml of distilled water was added to the control tubes, and to start the 
reactions in the test tubes, 0.2 ml of a solution containing 0.5 µmol of ATP was added. Control tubes were adjusted 
to zero absorbance in DU-7 spectrophotometer at 340 nm wavelength, and the increase in absorbance in the test 
tubes at this wavelength was plotted against time period of 15 min. Total enzyme activities (GCK + HXK and HXK 
activities) were calculated in terms of mU/ml of the liver supernatant. One milliunit of the enzyme corresponds to 
the amount of the enzyme producing 1 nmol of NADH per min under assay conditions at 25oC. Hexokinase 
activities were subtracted from the total HXK + GCK activities to obtain glucokinase activities. Protein content of 
liver homogenates was determined by using bicinchoninic acid (BCA) protein assay reagent (Pierce Chemical 
Company, Rockford, Chicago, USA) (Levinie et al., 1990). 
 
Measurement of Oxidative Phosphorylation 
Isolation of mitochondria 
Mitochondria were isolated and purified using the method of Kristal et al., (1997). The harvested liver 
tissues were placed in an ice-cold solution containing 250 mM mannitol, 70 mM sucrose, 500 µM EDTA and 5 mM 
HEPES, all at pH 7.4. The liver tissues were homogenized with a motor-driven glass Telfon pestle. Following 
homogenization, samples were centrifuged at 1000 g for 10 min. Supernatants were removed and centrifuged at 
10800 g for 15 min. Pellets were washed twice with the same solution but without EDTA, and re-spun at 10000 g 
for 5 min. Following the final wash, mitochondria were resuspended in a solution containing 120 mM KCl and 
50mMTris-HCl. 
Assay of Oxidative Phosphorylation   
                  The respiration of the isolated mitochondria was measured polarographically by using a Gilson model K-      
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ICT-C Oxygraph fitted with a Clark-type electrode in a 2-ml stirred vessel at 30oC. The signal was recorded with a 
HealthKit strip Chart Recorder. The vessel contained a suspension of mitochondria (4–6 mg protein) in 0.25 M 
sucrose; 10 mM potassium phosphate; 5 mg/mL albumin; 5 mM MgSO4, at pH 7.4, in a total volume of 2.2 mL. 
After 4–5 minutes temperature equilibration, the endogenous rate of oxygen uptake was recorded before adding 
exogenous substrate in 50 µL through the capillary stem of the oxygraph vessel. The substrate stock solutions used 
were 0.385 M glutamate/0.115 M malate, 0.5 M succinate, 0.385 M pyruvate/0.115 M malate; 0.385 M 
ornithine/0.115 M malate; and 0.385 M arginine/0.115 M malate. After recording oxygen uptake for another 4–5 
minutes, 0.8 µmoles ADP, at pH 7.4, was added, and oxygen uptake was recorded for another 3–6 minutes. This 
measurement allowed calculation of the rate of state 3 (ADP-stimulated) respiration (V3), the rate of state 4 (non-
ADP-stimulated) respiration (V4), the respiratory control index (RCI = V3/V4), and the phosphate to oxygen ratio 
(ATP generated divided by oxygen consumed in state 3).  
 Oxidative phosphorylation was also monitored spectrophotometrically by the method described by Singer 
(1974). Phosphorylation coupled to the first and second sites was measured with ferricyanide as the electron 
acceptor. Phosphorylation coupled specifically to the third site was measured with ascorbate + N,N,N,´N´-
tetramehtyl-p-phenylenediamine (TMPD). When succinate or ascorbate was used as electron donor, rotenone (10 
µg) was added to the reaction system. Activities were expressed as a percentage of control (µmoles of ferricyanide 
reduced/min/mg protein) at 30oC. Protein was measured by the Bio-RadTM Protein assay, using bovine serum 
albumin as standard (Lowry et al., 1951). The assay of oxidative phosphorylation was carried out soon after 
isolation of the mitochondria, and was completed within 1-2 h after mitochondrial isolation. 
 
Enzyme assays 
 
The activity of ATPase (ATP phosphohydrolase) was determined as described by Katyare and Satav 
(1986). Mitochondria concentration (300 µg of protein) and time of incubation (1 min or 4 min) were so adjusted as 
to ensure linearity in both the latent and the uncoupler-stimulated activity. Measurements of glutamate 
dehydrogenase (GDH), β-hydroxybutyrate dehydrogenase (BDH) and succinate dehydrogenase (SDH) activities 
were done according to the method of Katyatre and Satav (1986). In all determinations of the enzyme activities and 
rates of oxidative phosphorylation, an equal number of ‘control’ and experimental ‘test’ samples were used at any 
one time, to minimize errors due to variations. 
 
Estimation of cytochrome content 
 
The isolated mitochondria were washed repeatedly with acetone, chloroform/methanol (2:1, v/v) and 
acid/acetone as described by Bessman and Mohan (1997). Mitochondrial cytochrome contents were determined 
spectrophotometrically from the different mitochondrial spectra after solubilization (reduced–oxidized) of the 
pyridine haemochrome. 
 
Statistical analysis 
 
Results are expressed as means (±SEM). Statistical evaluation of the data obtained was done by Students’ t-
test. P values less than 0.05 were considered to be statistically significant. 
 
 
Results 
Acute toxicity testing 
 
Intraperitoneal administrations of relatively low doses of Artocarpus communis (Forst.) root-bark aqueous 
extract (1–50 mg/kg) were found to be safe in rats. However, relatively moderate to high doses of the plant’s extract 
(>100 mg/kg i. p.) were found to be toxic and/or lethal to the animals. The LD50 value of the plant’s extract was 
found to be 135±16 mg/kg i. p. in rats. This relatively low LD50 value of 135±16 mg/kg probably suggests that 
Artocarpus communis (Forst.) root-bark aqueous extract is toxic to rats. 
 
Blood glucose and serum insulin levels 
 
The changes in blood glucose and serum insulin levels, and changes in body and liver weights of the four 
animal groups studied are shown in Table 1. The three treated rat groups, A (ACE-treated), B (STZ-treated) and C 
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(STZ-+ACE-treated) showed significant increase (p<0.05) in blood glucose levels when compared with the control 
group D rats. After 3 weeks, the blood glucose concentration of the ACE-treated group A rats started to drop, but it 
never attained group D rats normoglycemic level throughout the study period (Table 1). There was a progressive 
decrease in the body weights of the rats in groups A, B and C, whereas the body weights of the control  group D rats 
showed moderate but insignificant (p>0.05) increase (Table 1). Furthermore, there was a significant decrease 
(p<0.05) in the serum insulin levels of the rats in the three treated groups A, B and C when compared with group D 
control rats. 
  
Hexokinase and glucokinase activities 
 
Table 2 shows the effects of A. communis root-bark aqueous extract on hepatic hexokinase and glucokinase 
activities. In groups A, B and C treated rats, both hexokinase and glucokinase activities significantly decreased 
(p<0.05) when compared with the group D control rats.   
 
Table 1.  Changes in blood glucose concentrations, serum insulin contents, body and liver weights of ACE-, STZ-, 
and STZ- + ACE-treated rats. 
 
Blood glucose concentrations (mmol/L) 
                                       Control                                                 Treated 
Days/Treatments                  0                          10                     20              30          40         
ACE-treated                    4.1±0.1                22.7±0.4a            18.6±0.2a            14.2±0.1a         10.7±0.5a 
STZ-treated                     4.2±0.6                18.8±0.2b            20.2±0.4b            21.4±0.3b         21.2±0.1b    
STZ + ACE-treated         4.0±0.2                22.6±0.4c            21.6±0.2c            20.5±0.3c         18.9±0.4c          
Serum insulin concentrations (µU/ml) 
ACE-treated                     13.0±1.1             11.5±1.3a             9.7±1.2 a              9.0±1.7 a          8.9±1.5 a 
STZ-treated                      12.8±1.5             8.5±1.4b              6.3±1.4b               5.9±1.3b          5.7±2.3b          
STZ + ACE-treated          12.2±1.2            10.3±1.2c            10.6±1.1c              10.9±1.7c        11.5±1.2c       
Body weights (g)              ACE                    STZ-treated              STZ + ACE-treated              Control                       
                                         212±11                    217±14b                        221±06a                         242±10a                       
Liver weights (g)             7.79±0.2                  8.27±0.5                       8.56±0.4                        9.46±0.8 
Values are expressed as means (±SEM) of 10 rats for all groups. a,b,c Significant difference (p<0.05) in the same row 
between various treatments and control group D rats. 
 
Table 2. Effects of A. communis root-bark aqueous extract on hepatic hexokinase and glucokinase activities of 
ACE-, STZ-, and STZ- + ACE-treated rats.  
 
Parameters             ACE-treated       STZ-treated          STZ + ACE-treated      Control      
 
 
Liver HXK               1.12±0.3a           1.32±0.7b               1.42±0.5c                 2.66±0.3                
Liver GCK               1.04±0.1a           1.18±0.6b               1.25±0.7c                 5.21±0.4                
 
Values are expressed as means (±SEM) of 10 rats for all groups. a,b,c Significant difference (p<0.05) in the same row 
between various treatments and control group D rats. Values are expressed as mU/mg protein. 
 
Oxidative phosphorylation 
Early effects  
 
 The oxidative activities of hepatic mitochondria in the four groups (A, B, C and D) of rats are shown in 
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Tables 3 and 4.  At one week of diabetic state, state 3 respiration rates (ADP present) of the rats in groups A, B and 
C did not change the rate of oxidative phosphorylation for glutamate, β-hydroxybutyrate or ascorbate + TMDP. 
However, there was a significant increase (p<0.05) in succinate, and decrease in pyruvate + malate. The changes in 
the state 4 respiration rate (after depletion of added ADP) were significantly lower (p<0.05) for GDH, BDH and 
ascorbate, and higher for SDH, but minimal for pyruvate. The respiratory control ratios (state 3 respiration rate/state 
4 respiration rate) were generally high, and in the expected ranges for the substrates used. Diabetes affected only the 
oxidative activity of mitochondria, but the ability of mitochondria to phosphorylate (P/O ratio) remained unaffected. 
Thus, diabetic state did not cause any uncoupling of mitochondria at this early stage (Table 3). The primary 
dehydrogenases, especially GDH and BDH, showed significant increase (p<0.05), but the increase in SDH was 
dramatically high (p<0.05), despite the increase in state 3 respiratory activity (Table 3). Furthermore, in groups A, B 
and C animals, the contents of cytochromes b and c + c1 significantly decreased (p<0.05), while those of aa3 was 
only marginal when compared with those of the control group D rats (Table 6).  
 
Late effects 
 
At the end of 4 weeks when the diabetic state was fully established, the state 3 respiration rate was 
insignificantly decreased (p>0.05) for the different substrates used, and no change was observed for ascorbate + 
TMPD (Table 4). The state 4 respiration rates were elevated for NAD+-linked substrates and succinate in the 
diabetic rats. The ADP/O ratios were also not affected; thus, even at the late stage of the disease, mitochondria were 
well coupled. ADP phosphorylation rates correlated well with the observed changes in the respiration rates (Table 
4). The contents of cytochrome aa3 significantly increased (p<0.05) in groups A, B and C diabetic rats, while those 
of b and c + c1 significantly decreased (p<0.05) when compared with the control group D rats (Table 6).  
 
ATPase activity 
 
In the early diabetic stage (week 1), the basal and Mg-stimulated ATPase activities were insignificantly 
lower (p>0.05), while the +DNP and Mg2+ + DNP-stimulated ATPase activities were significantly decreased 
(p<0.05) in groups A, B and C rats compared with the control group D animals. At the end of 4 weeks, the basal and 
Mg-stimulated ATPase activities still remained lower, while the +DNP and Mg2+ + DNP-stimulated ATPase 
activities increased in groups A, B and C rats, compared with the control group D animals (Table 5). 
 
Ultrastructural changes 
 
Groups A, B and C diabetic rats showed similar ultrastructural changes and alterations. The most common 
findings in these animals as revealed by electron microscopy were the presence of lipid droplets and 
intracytoplasmic vacuoles (Fig. 1). Other remarkable changes within the cytoplasmic organelles of the animals 
included mitochondrial membranes that were poorly preserved, scanty rough endoplasmic reticulum and increased 
number of vesicular structures. Lysosome-like structures were seen in greater numbers among the group A rats. The 
control group D animals maintained normal architecture of the hepatocytes. Their organelles were viable, and they 
were in normal proportions. 
 
 
Discussion 
 
  Artocarpus communis (Forst.) root-bark aqueous extract (≥135 mg/kg i. p.) is toxic to rats. This finding is 
quite intriguing because decoctions and infusions of A. communis root-bark are traditionally used by the Yoruba-
speaking people of Western Nigeria as an effective folk remedy for the management, control and/or treatment of 
type 2, adult-onset diabetes mellitus (with no reported adverse effect to date). The ‘toxicity’ of A. communis root-
bark aqueous extract observed in the present study confirms our earlier unpublished pilot study which showed that 
A. communis root-bark aqueous extract is not only lethal to rats at moderate to high doses, but also that it induces 
hyperglycaemia in Wistar rats at all dose levels. In view of the observed hyperglycaemic and toxic effects of A. 
communis root-bark aqueous extract in rats, the present study was undertaken to compare the glycaemic, metabolic 
and ultrastructural effects of A. communis root-bark aqueous extract (ACE) with those of streptozotocin (STZ) in 
rats and various hepatic tissues of rats. 
It is an established fact that structural damage to organs and tissues, or complications of diabetes mellitus, 
may be due to oxidative stress.  Oxidative stress may play an  important  role  in  the  development  of  STZ-induced 
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Table 3: Early effects of ACE and STZ treatments on oxidative energy metabolism in rat liver mitochondria. 
Substrate          ADP/O ratio          Respiration rate                     ADP phosphorylation rate      
Treatment                                  (nmol O2/min/mg protein)           (nmol/min/mg protein) 
                                                   + ADP                  - ADP  
 
Glutamate 
ACE                 2.91±0.2            37.1±1.2        0.7±0.2*               229.7±6.9**                                              
STZ                  2.89±0.1            36.9±1.2        0.6±0.2*               231.9±8.4** 
STZ + ACE      3.01±0.2            37.2±1.1        0.6±0.2*               234.8±9.3** 
Control             2.81±0.1            36.7±1.2        1.0±0.1               213.6±7.5 
 
β-hydroxybutyrate 
ACE              2.83±0.1            34.3±1.7        0.6±0.2*               195.7±7.8**           
STZ                  2.92±0.2            35.2±1.4        0.5±0.1*               198.9±8.4** 
STZ + ACE      3.03±0.1            36.5±1.3        0.5±0.1*               203.6±5.7** 
Control             2.82±0.2            32.7±1.8        1.2±0.2               180.9±6.5 
 
Succinate 
ACE              1.93±0.3            92.4±1.3**       2.9±0.1**               295.4±7.7**  
STZ              1.97±0.2            95.3±1.6**       3.1±0.2**               309.8±5.8** 
STZ + ACE      2.01±0.1            91.5±1.7**        3.5±0.2**               312.6±7.9** 
Control             1.82±0.5            72.4±1.5        1.9±0.3               280.4±9.7  
 
Pyruvate + Malate 
ACE                 2.96±0.2            26.5±1.1        0.7±0.2*               155.7±6.9* 
STZ                  3.03±0.1            24.9±1.0        0.8±0.3*               158.6±8.9* 
STZ + ACE      3.05±0.2            23.8±1.3        0.7±0.2*               156.4±7.9* 
Control             2.95±0.2            31.4±1.2         1.2±0.1               183.5±9.9 
 
Ascorbate + TMPD 
ACE              0.65±0.1*          62.9±1.5*        19.3±1.5*               55.7±9.9*   
STZ              0.72±0.2*          65.6±1.7*        20.5±1.9*               57.6±7.5* 
STZ + ACE      0.70±0.2*          63.7±1.8*        18.9±1.8*               53.9±6.7* 
Control             0.81±0.2            76.5±1.4        26.8±1.6               68.4±7.8 
 
Values are expressed as means (±SEM) of 10 rats for all groups. Oxygen uptake is expressed as ng-atomsO/min per 
mg of mitochondrial protein *Significant decrease (p<0.05) when compared with the control group D animals. 
**Significant increase (p<0.05) in the same column between treatment and control group D rats. 
 
 
 
diabetes, and mitochondria are suggested to be one of the targets in STZ-induced toxicity (Bastar et al., 1998). 
Mitochondria are special organelles in eukaryotic cells that efficiently convert energy available in substrate 
molecules to the universal fuel, ATP, for cellular processes. Oxidative phosphorylation is a key pathway used by 
most aerobic cells to harvest energy, and about 40-50% of ATP in the liver is produced by mitochondria. Therefore, 
the normal function of all other processes within the liver cells is ultimately dependent on the energy production in 
mitochondria. Disturbance of mitochondrial function underlies many metabolic diseases (Hall et al.,1960). For this 
reason, evaluation of dysfunction of oxidative phosphorylation is often given crucial importance in biomedical and 
toxicological investigations. 
From the data obtained in this study the animals treated with A. communis root-bark aqueous extract alone 
developed acute and severe hyperglycemia, faster than the STZ- and STZ- + ACE-treated groups of animals. The 
plant’s extract also produced moderate body and liver weight losses. Serum insulin levels of the plant’s extract-
treated rats were significantly reduced (p<0.05), but still slightly higher than those of the STZ-treated group B rats. 
However, there was a decrease in blood glucose concentrations of the ACE-treated rats as from the 3rd week of our 
study, but the blood glucose levels of the animals failed to reach the normoglycemic levels of the control, group D 
rats. 
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Table 4. Late effects of ACE and STZ treatments on oxidative energy metabolism in rat liver mitochondria. 
Substrate          ADP/O ratio          Respiration rate                     ADP phosphorylation rate      
Treatment                                  (nmol O2/min/mg protein)           (nmol/min/mg protein) 
                                                   + ADP                  - ADP  
 
Glutamate 
ACE                 2.52±0.1*          28.3±1.3*        1.4±0.2**               147.5±6.5*                                                
STZ                  2.43±0.1*          26.9±1.5*        1.6±0.2**               149.7±5.9* 
STZ + ACE      2.39±0.2*          27.3±1.4*        1.5±0.2**               151.8±7.4* 
Control             3.05±0.2            38.5±1.2        1.1±0.1               212.4±6.5 
 
β-hydroxybutyrate 
ACE              2.59±0.3*          23.5±1.7*        1.6±0.1**               129.5±9.4*             
STZ                  2.62±0.2*          26.7±1.6*        1.4±0.2**               125.9±8.6* 
STZ + ACE      2.56±0.2*          24.6±1.4*        1.5±0.1**               127.7±7.7* 
Control             2.92±0.2            36.9±1.3        0.6±0.2               197.8±6.8 
 
Succinate 
ACE              2.03±0.2            59.1±1.1*        4.3±0.3**               215.7±8.7*  
STZ              2.01±0.1            56.3±1.4*        4.4±0.2**               209.8±9.8* 
STZ + ACE      2.02±0.1            54.2±1.3*        4.5±0.5**               212.9±8.9* 
Control             1.84±0.3            81.1±1.2        2.6±0.3               282.9±9.9  
 
Pyruvate + Malate 
ACE                 2.56±0.2            22.5±1.1*        1.0±0.3               115.7±8.3* 
STZ                  2.63±0.2            21.4±1.2*        1.1±0.2               112.6±7.5* 
STZ + ACE      2.55±0.2            23.5±1.4*        1.2±0.2               116.7±7.8* 
Control             2.95±0.2            34.6±1.2         0.8±0.1               187.9±9.7 
 
Ascorbate + TMPD 
ACE              0.63±0.3*          67.5±1.5*        27.3±1.5*               52.4±6.2*   
STZ              0.69±0.2*          65.3±1.7*        26.2±1.2*               54.3±5.1* 
STZ + ACE      0.68±0.2*          66.5±1.8*        28.0±1.3*               51.2±6.0* 
Control             0.82±0.2            79.2±1.4        36.2±1.4               62.4±7.0 
Values are expressed as means (±SEM) of 10 rats for all groups. Oxygen uptake is expressed as ng-atomsO/min per 
mg of mitochondrial protein. *Significant decrease (p<0.05) when compared with the control group D animals. 
**Significant increase (p<0.05) in the same column between treatment and control group D rats. 
 
Table 5: Effects of ACE and STZ treatments on ATPase activities in rat liver mitochondria. 
 
Duration          Animals                 ATPase activity (nmol of Pi liberated/min/mg protein) 
                                                     
                                                     -Mg2+ -DNP       +Mg2+      +DNP      +Mg2+ +DNP  
 
One week       ACE          1.5±0.2*        1.4±0.3*     7.2±0.3*          7.0±0.4*   
                        STZ          1.4±0.3*        1.6±0.2*     7.1±0.5*          7.3±0.5* 
  STZ + ACE         1.6±0.2*         1.7±0.3*     7.6±0.2*          7.1±0.3* 
  Control         1.9±0.1        1.9±0.1       12.1±0.1          9.7±0.2 
 
Four weeks ACE          1.0±0.1*        1.4±0.2*   12.0±0.3**       11.5±0.3**    
STZ          1.2±0.2*        1.3±0.1*   12.3±0.5**       12.0±0.4** 
STZ + ACE         1.4±0.2*        1.6±0.2*   13.4±0.2**       12.6±0.5** 
Control         2.0±0.1        1.9±0.3   10.2±0.1           10.2±0.1 
Values are expressed as means (±SEM) of 10 rats for all groups. *Significant decrease (p<0.05) when compared 
with the control group D animals. **Significant increase (p<0.05) in the same column between treatment and 
control group D rats. 
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Table 6:  Effects of ACE and STZ treatments on cytochrome contents in rat liver mitochondria. 
 
Duration          Animal                       Cytochrome contents (p mol/mg protein) 
                        Groups                           
                                                              Aa3                        b                          c + c1  
 
One week       ACE          126.0±8.0*    181.0±4.0*           329.0±7.0*           
                        STZ          125.0±5.0*    179.0±5.0*           331.0±5.0*          
  STZ + ACE         123.0±6.0*    185.0±3.0*           336.0±7.0*           
 Control         139.0±4.0    223.0±7.0             405.0±9.0        
 
Four weeks ACE          156.0±7.0**           182.0±6.0*       293.0±7.0*  
STZ          162.0±5.0**           187.0±7.0*       289.0±6.0*    
STZ + ACE         167.0±4.0**           191.0±4.0*       207.0±8.0*        
Control         142.0±6.0               221.0±5.0        397.0±9.0        
 
Values are expressed as means (±SEM) of 10 rats for all groups. *Significant decrease (p<0.05) when compared 
with the control group D animals. **Significant increase (p<0.05) in the same column between treatment and 
control group D rats. 
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Figure1: Effects of ACE and STZ treatments on dehydrogenase activities in rat liver mitochondria. Values are 
expressed as means (±SEM) of 10 rats for all groups. Activities of all the substrates used were significantly 
decreased (p<0.05) 4 weeks post-treatment. 
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Figure 2: Micrographs illustrating hepatocyte contents of groups A, B, C and D animals used. Groups A, B and C 
rats showed poor organization of the organelles within the cytoplasm. (A) shows ACE-treated rat with giant 
liver glycogen (g), lipid droplets (p), multiple vacuoles and poor architecture of the cytoplasm. The arrow 
shows myelin formation within the glycogen. (B) shows STZ-treated rat with hepatic lipid droplets (p), 
mitochondria with poor inner membrane (m) and absence of rough endothelial reticulum. (C) shows STZ- 
+ ACE-treated rat liver with multiple swollen mitochondria and patchy glycogen. (D) shows control rat’s 
liver with normal organization of the organelles in relative proportions, intact rough endothelial reticulum 
(rer), nucleus (n) and mitochondria (m). Final magnification was at X15, 000.   
 
 
Glucokinase (GCK) is the glucose sensing enzyme that is responsible for the phosphorylation of the 
majority of glucose in the liver and in the pancreas. GCK binds to and phosphorylates glucose when its levels are 
higher than normal, thus allowing it to maintain constant glucose levels (Kamata et al., 2004). In the present study, 
hepatic hexokinase (HXK) and GCK were observed to be lower. This observation is in agreement with the findings 
of Postic et al., (2001). GCK activity was lower in the ACE-, STZ-, and STZ- + ACE-treated diabetic rats as 
compared with the control group D rats. The decrease in hepatic GCK could result from hypoinsulinaemia, or 
decreased synthesis and/or increased degradation of GCK by oxidative stress in diabetes (Matschinsky and 
Magnuson, 2004).  
 In several mitochondrial studies, changes in separate functional parameters, such as rate of respiration in 
metabolic states 3 and 4, and/or uncoupled state, membrane potential and swelling, are measured with the aim of 
evaluating the influence of different effectors or damaging factors on oxidative phosphorylation. The present study 
has demonstrated that A. communis root-bark aqueous extract, concentrations, affected many sites in the machinery 
of mitochondrial energy transformation. It increased the membrane leak and inhibited both the respiratory and the 
phosphorylation subsystems, thus causing a slight (succinate oxidation) or substantial change (glutamate + malate 
oxidation) in mitochondrial membrane potential. The resulting change in mitochondrial membrane potential may 
serve as a sensitive measure to evaluate the degree to which different blocks are affected. This observation is in 
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agreement with the findings of Nishihara et al., (1986), and Kavanagh et al., (2000). Oxidative phosphorylation is 
the terminal process of cellular respiration in which ATP is formed. Thus, during oxidative phosphorylation, 
electrons are transferred from NADH or FADH2, created in glucolysis, fatty acid metabolism and the Krebs circle, 
to molecular oxygen via a series of protein complexes located in the inner mitochondrial membrane (Leninger and 
Cox, 2001). The results of the presented study gave clear, discernible indications that diabetes at the early stage, 
causes a decline of respiration with pyruvate + malate. Our results also show that there was a transient increase in 
the rate of succinate oxidation, impairment of β-hydroxybutyrate and succinate dehydrogenases activities. These 
findings are probably due to a specific decrease in one or more of the electron-transport components. The liver 
mitochondria were well coupled with intact ADP/O ratios and the respiratory control ratios. Cytochromes b and c + 
c1 contents were also decreased, but none of these changes altered respiration rate at this initial stage of the disease. 
Indeed, the ADP-phosphorylation rates were not significantly affected (p>0.05), but ATP-synthesizing potential, as 
judged by the ATPase activities, significantly decreased (p<0.050. Late diabetic state gave a clearer picture of 
oxidative stress, with the state 3 respiration rates decreased uniformly and significantly (p<0.05) with all the 
substrates, except ascorbate + TMPD. The decreased respiration rates in groups A, B and C diabetic rats were 
correlated with the decreased contents of cytochromes b and c + c1, but increased aa3 content. The increase in aa3 
content may, however, possibly be an attempt to increase oxidative potential. The ATP-synthesis rate also decreased 
in groups A, B and C diabetic rats, and this followed a pattern compatible with respiration rates, since any factor 
disturbing the activity of the respiratory subsystem via induced changes in mitochondrial membrane potential will 
elicit secondary effects on phosphorylation flux.  
The β-hydroxybutyrate dehydrogenase activity serves as a clear pointer to diabetic state, and this is well 
recognized with ketoacidosis in diabetes (Rogers et al., 1986). It is thus clear from our results that the early and the 
late effects of diabetic state on hepatic mitochondrial oxidative energy metabolism differ. Also, the mitochondrial 
architecture differed significantly from the normal ones with respect to the contents of the dehydrgenases, 
cytochromes and the ATPase activities. Our study has shown that a disturbance in the activity of all the three 
subsystems contributes to the overall inhibition of oxidative phosphorylation. Our results have also revealed several 
individual components within the system that are sensitive to the toxic effects of A. communis.  
We conclude that A. communis root-bark aqueous extract has a toxic, non-specific hepatic action, since it 
affects membrane leak, dehydrogenases, cytochromes b and c + c1 in the respiratory chain, and ATPase. The extent 
to which these effects are caused by changes in the composition and properties of the mitochondrial membrane, and 
the lipid environment that is essential for the normal function of the membrane proteins, can only be speculated. 
Whatever may be the molecular details of A. communis root-bark aqueous extract, and its interaction with 
components of oxidative phosphorylation, it is obvious from the present study that by acting simultaneously on 
many steps and enzyme systems, the plant’s extract efficiently inhibits the physiologically important features of 
respiration and ATP synthesis in liver mitochondria. 
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